Codelivery of a tea extract prevents morbidity and mortality associated with oral vanadate therapy in streptozotocin-induced diabetic rats.
Oral administration of vanadate has a strong hypoglycemic effect but results in toxic side effects like life-threatening diarrhea. Tea is known to have potent antidiarrhea effects. We investigated the potential of suspending the vanadate in a tea decoction to reduce the diarrheatic action of vanadate. A concentrated extract of Lichee black tea was, therefore, added to sodium orthovanadate. Streptozotocin (STZ)-induced diabetic rats were orally gavaged with vanadate suspended in water or in the tea decoction, or with the tea extract alone. Blood glucose levels were assessed daily over 11 weeks with levels greater than 10 mmol/L warranting therapeutic intervention. Both the vanadate/water and vanadate/tea solutions acutely reduced blood glucose. The tea extract alone had no effect. The majority of vanadate/water-treated rats developed diarrhea and mortality rates approached 40%. Vanadate/tea-treated diabetic rats experienced no diarrhea or mortality and liver and kidney analyses (plasma ALT and creatinine, blood urea nitrogen [BUN], and urine-specific gravity) were normal. Animals treated with vanadate/tea retained blood glucose levels less than 10 mmol/L for an average of 24 consecutive days without subsequent treatments. Cataract formation was completely prevented. The mechanism of action of vanadate may have involved beta-cell stimulation because vanadate/tea-treated diabetic rats exhibited normal plasma insulin levels. In summary, because of its long-lasting effects, oral administration, and lack of side effects, vanadate/tea represents a potentially important alternative therapy for an insulin-deficient diabetic state.
Clark
Tod A
TA
The National Centre for Agrifood Research in Medicine, University of Mannitoba, Winnipeg, Canada.
Heyliger
Clayton E
CE
Edel
Andrea L
AL
Goel
Danny P
DP
Pierce
Grant N
GN
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D002386:Cataract / Q000453:epidemiology; D002784:Cholesterol / Q000097:blood; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D003967:Diarrhea / Q000453:epidemiology / Q000401:mortality; D004326:Drinking; D004435:Eating; D007004:Hypoglycemic Agents / Q000627:therapeutic use* / Q000633:toxicity*; D008111:Liver Function Tests; D008297:Male; D010936:Plant Extracts / Q000627:therapeutic use; D051381:Rats; D017207:Rats, Sprague-Dawley; D013662:Tea; D014280:Triglycerides / Q000097:blood; D014638:Vanadates / Q000493:pharmacokinetics / Q000627:therapeutic use* / Q000633:toxicity*
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D010936:Plant Extracts; D013662:Tea; D014280:Triglycerides; D014638:Vanadates; D002784:Cholesterol